A verified TB-500 COA confirms sequence identity, high chromatographic purity, and non-detectable endotoxin levels for precise laboratory investigation. PX1 Research provides lot-specific certificates of analysis for all synthesis batches, ensuring empirical accuracy across cellular migration, actin regulation, and angiogenesis research models. Every batch undergoes rigorous ISO 17025 accredited testing prior to laboratory dispatch.
A verified TB-500 COA confirms sequence identity, high chromatographic purity, and non-detectable endotoxin levels for precise laboratory investigation. PX1 Research provides lot-specific certificates of analysis for all synthesis batches, ensuring empirical accuracy across cellular migration, actin regulation, and angiogenesis research models. Every batch undergoes rigorous ISO 17025 accredited testing prior to laboratory dispatch.
In peptide synthesis and analytical biochemistry, a Certificate of Analysis (COA) serves as the primary document verifying chemical identity, quantitative purity, and batch consistency. For investigators utilizing TB-500 10mg, evaluating a comprehensive **tb-500 coa** is critical to rule out organic impurities, truncated sequences, residual reagents, or microbial contamination that could skew empirical findings in cell culture or animal models.
A compliant certificate of analysis must originate from an independent, ISO 17025-accredited testing facility using standardized analytical methodology. Key analytical metrics reported on a valid **tb-500 coa** include Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) chromatograms, Electrospray Ionization Mass Spectrometry (ESI-MS) spectra, net peptide content, appearance assessment, and Limulus Amebocyte Lysate (LAL) endotoxin quantification.
PX1 Research ensures complete lot traceability by pairing every batch of research peptides with an authentic, unedited report. Researchers can cross-examine batch numbers directly on the physical vial and digital documentation to confirm that the material meets strict analytical thresholds required for reproducible preclinical experimentation.
TB-500 is a synthetic peptide derivative corresponding to the active region (specifically the N-terminal acetylated peptide sequence LKKTETQ) of Thymosin Beta-4. In structural biochemistry research, this truncated hexapeptide motif is studied for its role in G-actin sequestration and cell migration signaling cascades. When evaluating a **tb-500-coa**, researchers must confirm the precise molecular mass and primary amino acid sequence against theoretical targets.
The molecular formula of synthetic TB-500 (Ac-LKKTETQ) yields a theoretical molecular weight of approximately 889.05 g/mol. A legitimate analytical report will explicitly state both the theoretical mass and the observed mass detected via mass spectrometry. Discrepancies greater than standard instrument tolerance limits (typically ±0.5 Da) indicate potential amino acid substitution, incomplete deprotection, or improper synthesis protocols.
Preclinical researchers studying soft-tissue recovery, cell motility, and cytoskeletal remodeling rely on exact sequence fidelity. Even minor modifications in the LKKTETQ motif can significantly alter actin binding dynamics in vitro. Therefore, verifying sequence integrity via mass spectrometry analysis on the tb-500 coa is an indispensable preliminary step before initiating biochemical assays.
Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) is the gold standard method for determining the chromatographic purity of synthetic peptides. On a standardized **tb-500 coa**, the HPLC section provides a detailed visual chromatogram along with a peak integration table that quantifies the relative abundance of the target peptide relative to baseline contaminants.
The analytical method typically employs a C18 stationary phase column under an acetonitrile/water gradient containing 0.1% trifluoroacetic acid (TFA) as an ion-pairing agent, monitored at a UV wavelength of 214 nm or 220 nm (where peptide bonds absorb strongly). A single sharp peak corresponding to the target retention time indicates high chemical purity, while secondary shoulder peaks or baseline noise denote synthesis artifacts, deleted sequences, or degradation products.
PX1 Research enforces a minimum purity threshold of ≥98.0% for all catalog compounds. By inspecting the area-under-the-curve (AUC) calculation on our published COAs, laboratory personnel can verify that residual organic solvents and truncated side-products are minimized, preventing confounding variables during sensitive cellular assays.
While RP-HPLC measures purity by separating chemical components based on hydrophobic interaction, Mass Spectrometry (MS) confirms identity by measuring the exact mass-to-charge ratio (m/z) of the molecule. A valid **tb-500 coa** must include an ESI-MS or MALDI-TOF spectrum showing clear ionization peaks corresponding to the target structure.
In ESI-MS spectra for TB-500, primary signal peaks typically register as singly protonated [M+H]+ or doubly protonated [M+2H]2+ ions. The presence of unexpected high-intensity mass peaks suggests adduct formation, residual protecting groups (such as Pbf or tBu), or sequence oxidation. Thorough inspection of the mass spectrum prevents researchers from utilizing misidentified or partially degraded peptide lots.
To maintain rigorous scientific standards, PX1 Research includes full-spectrum mass spectrometry graphs within our documentation hub. Researchers can access detailed data on our analytical testing library to cross-reference mass spectra before introducing materials into experimental protocols.
Bacterial endotoxins (lipopolysaccharides derived from the outer membrane of Gram-negative bacteria) pose a severe threat to biological assays. Even minute endotoxin contamination can trigger inflammatory signaling pathways, alter cell viability, or induce artifactual macrophage activation in vitro. Consequently, an acceptable **tb-500 coa usa** standard must include explicit LAL endotoxin quantitative testing.
PX1 Research subjects all peptide lots to Kinetic Chromogenic LAL (Limulus Amebocyte Lysate) assays to ensure endotoxin levels remain below strictly defined laboratory limits (typically <0.05 EU/mg, and often below detectable limits). This level of control is essential for cell culture studies, endothelial cell tube-formation assays, and tissue-engineering research.
Furthermore, our peptides undergo sterile filtration prior to lyophilization in ISO 7 cleanroom environments. The resulting cake or powder exhibits minimal moisture content, maximizing long-term stability and ensuring that reconstituted solution behavior remains predictable across repeated trial runs.
When sourcing research compounds, verifying domestic synthesis and US-based analytical validation is vital for lab reproducibility. A **tb-500 coa usa** report indicates that testing was conducted under strict regulatory oversight using standardized US Pharmacopeia (USP) or equivalent international standards.
Imported or unverified peptides frequently suffer from batch-to-batch variation, uncalibrated HPLC baseline integration, or omitted endotoxin screens. In contrast, PX1 Research operates with full US-based supply chain transparency. All products are synthesized in state-of-the-art facilities, with lot-specific analytical validation performed in independent domestic laboratories.
To support rapid experimental schedules, PX1 Research provides same-day dispatch (Monday through Friday) for all orders placed before cut-off times, shipping directly from specialized fulfillment centers in California and Arizona. This eliminates international shipping delays, customs degradation risks, and cold-chain uncertainties.
Preclinical investigation into TB-500 focuses primarily on its function as an actin-monomer sequestering peptide. In vitro studies demonstrate that the active LKKTETQ sequence binds globular actin (G-actin), regulating the dynamic equilibrium between G-actin and filamentous actin (F-actin). This biochemical interaction is fundamental to cell motility, lamellipodia formation, and structural remodeling in damaged cell monolayers.
In rodent and cell culture models, TB-500 has been evaluated for its capacity to stimulate endothelial cell migration and capillary-like tube formation (angiogenesis). Preclinical data suggest that promoting localized vascularization supports the delivery of oxygen and nutrients to damaged collagen matrices, accelerating tissue remodeling in soft-tissue injury models.
Additionally, ongoing research investigates the interaction of synthetic thymosin fragments with matrix metalloproteinases (MMPs) and inflammatory cytokines. Researchers interested in tissue regeneration pathways often compare these mechanisms alongside other regenerative molecules available in our all peptides catalog.
In regenerative biochemistry literature, researchers frequently evaluate TB-500 alongside full-length Thymosin Beta-4 and the pentadecapeptide BPC-157. While these compounds share overlapping areas of investigation—such as cell migration, vessel formation, and tissue remodeling—their chemical structures and target pathways differ distinctly.
TB-500 represents the short-chain functional region of Thymosin Beta-4, concentrating on actin sequestration and cell movement. Full-length Thymosin Beta-4 contains 43 amino acids and exhibits broader systemic signaling roles, though it is more complex to synthesize uniformly. Conversely, BPC-157 5mg operates through distinct growth factor expression pathways, including VEGFR2 upregulation and nitric oxide modulation, as detailed in our analysis of BPC-157 mechanism of action.
The following matrix summarizes key analytical and structural differences between these frequently paired research compounds:
| Compound | Molecular Mass | Sequence / Structure | Primary Research Focus | HPLC Purity Target | | :--- | :--- | :--- | :--- | :--- | | **TB-500** | ~889.05 Da | Ac-LKKTETQ (Hexapeptide) | Actin regulation, cell migration, angiogenesis | ≥98.0% | | **Thymosin Beta-4** | ~4963.5 Da | 43-Amino Acid Polypeptide | Systemic tissue repair, cell survival | ≥95.0% | | **BPC-157** | ~1419.5 Da | 15-Amino Acid Pentadecapeptide | VEGFR2 signaling, tendon/ligament healing | ≥98.0% |
Many investigative protocols examine potential synergy between distinct peptide classes. For instance, studies investigating tissue repair pathways may combine actin-sequestering compounds with growth hormone secretagogues such as CJC-1295 DAC 5mg or Ipamorelin 5mg to measure multi-pathway physiological response in controlled preclinical models.
To preserve peptide integrity and prevent degradation prior to assay execution, strict laboratory handling procedures must be observed. Lyophilized TB-500 powder should be stored in a dry environment at -20°C for short-term preservation or -80°C for long-term storage, protected from light exposure.
Reconstitution should be performed using laboratory-grade solvents such as sterile bacteriostatic water or 0.9% sodium chloride injection solution, depending on the requirements of the planned assay. The diluent should be introduced gently along the glass vial wall, allowing the lyophilized cake to dissolve naturally without violent agitation or vortexing, which can denature peptide secondary structures.
Once reconstituted, liquid aliquots should be stored at 2°C to 8°C for immediate use (typically within 14–28 days) or sub-aliquoted and frozen at -20°C to avoid repeated freeze-thaw cycles. Following these standards ensures that the chemical properties documented on the original **tb-500 coa** remain valid throughout the experimental timeline.
Academic institutions, biotechnology firms, and contract research organizations (CROs) require consistent supply chains with uncompromised lot-to-lot reliability. PX1 Research offers flexible volume options for institutional entities through our dedicated wholesale program.
Bulk orders undergo the same rigorous analytical testing protocols as individual vials. Every wholesale shipment includes lot-matched COAs, HPLC chromatograms, mass spectra, and endotoxin reports, ensuring complete compliance with institutional quality assurance requirements.
By pairing high-capacity domestic manufacturing with stringent ISO 17025 verification, PX1 Research stands as a premier US supplier of high-purity research peptides. Laboratory directors can request bulk quotes and technical documentation directly through our institutional client portal.
What information is included on an official tb-500 coa?
An official TB-500 Certificate of Analysis (COA) includes lot-specific details such as visual appearance, identity confirmation via Mass Spectrometry (MS), purity percentage calculated via Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC), residual endotoxin quantification via LAL assay, net peptide content, and manufacturer batch verification.
Why is a tb-500 coa usa verification important for research?
A domestic US-verified COA guarantees that the analytical testing was conducted according to rigorous ISO 17025 accredited laboratory standards. It ensures that purity metrics, mass identification, and endotoxin limits are transparently documented without third-party falsification or international supply chain degradation.
How do I read the HPLC chromatogram on a tb-500-coa?
The HPLC chromatogram displays light absorbance over time as the compound elutes through a C18 column. The primary peak represents intact TB-500. The area under this peak relative to secondary baseline peaks determines the total purity percentage, which PX1 Research requires to be ≥98.0%.
What is the theoretical molecular weight shown on a TB-500 mass spec report?
The theoretical molecular weight of synthetic TB-500 (N-acetylated LKKTETQ sequence) is approximately 889.05 Da. The mass spectrometry graph on the COA will display ionization peaks (such as [M+H]+) confirming this exact mass.
What are acceptable endotoxin levels on a TB-500 COA?
For cell culture and preclinical in vitro research, endotoxin levels should ideally remain below 0.05 EU/mg. PX1 Research enforces strict cleanliness protocols during synthesis and lyophilization to ensure non-detectable or ultra-low endotoxin scores on every COA.
How does TB-500 differ structurally from full-length Thymosin Beta-4?
TB-500 is a synthetic hexapeptide fragment corresponding to the active G-actin-binding sequence (LKKTETQ) of Thymosin Beta-4. Full-length Thymosin Beta-4 is a naturally occurring 43-amino acid protein. TB-500 specifically isolates the active site responsible for cell migration and actin sequestration.
What solvent should be used to reconstitute TB-500 for laboratory testing?
TB-500 is typically reconstituted using sterile bacteriostatic water or 0.9% sodium chloride solution for analytical procedures. Solvents should be added slowly along the vial wall without aggressive shaking to preserve peptide integrity.
How should reconstituted TB-500 be stored to maintain its COA purity standards?
Reconstituted TB-500 solutions should be stored at 2°C to 8°C for short-term experimentation (up to 28 days) or sub-aliquoted and kept at -20°C to -80°C for long-term storage, avoiding repeated freeze-thaw cycles.
Can I obtain a lot-specific COA prior to purchasing TB-500?
Yes, PX1 Research provides public access to lot-specific Certificates of Analysis directly on our product pages and analytical testing hub, allowing researchers to inspect HPLC and MS data prior to ordering.
Are PX1 Research compounds intended for human clinical use?
No. All products offered by PX1 Research, including TB-500, are strictly for laboratory research, in vitro experimentation, and preclinical scientific study. They are not for human or animal therapeutic, medical, or diagnostic use.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.